INSIGHTS ON DRUG DISCOVERY

• A Pre-Clinical Study For Diet-Induced Obesity

  Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

• Bleomycin-Induced Scleroderma Mouse Model For Preclinical Testing

  Get an in-depth overview of the bleomycin-induced scleroderma model, detailing its key specifications and presenting significant findings observed following bleomycin administration in study animals.

• Preclinical Evaluation Of Novel Drug Candidates Against SLE In NZB/W F1 Mouse Models

  Explore how the well-established NZB/W F1 mouse model enables the evaluation of novel anti-SLE therapeutics, providing critical insights into disease mechanisms and treatment efficacy.

• RSV Challenge Model For Anti-RSV Therapy

  Utilize advanced rodent models to accelerate the preclinical testing of your anti-RSV therapies and vaccines, advancing the fight against this widespread respiratory infection.

• DSS-Induced IBD Mouse Model For Preclinical Drug Screening

  3/27/2025

  Leverage our chemically induced murine model of Inflammatory Bowel Disease to accelerate your research on IBD and explore potential therapeutic interventions.

• Propelling Glioblastoma Research: Orthotopic Model Solutions

  3/27/2025

  Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

• AI-Powered Digital Pathology For Pulmonary Fibrosis Biomarker Quantification

  3/27/2025

  Uncover how AI-driven digital pathology is revolutionizing the detection and quantification of pulmonary fibrosis markers in whole lung sections, offering new opportunities for clinical research.

• Thunderstruck By Antibody-Drug Conjugates

  3/18/2025

  Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.

• Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

  3/12/2025

  Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.